Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 3
1973 3
1974 1
1976 1
1977 2
1978 3
1980 1
1981 2
1982 3
1983 4
1984 6
1985 1
1986 4
1987 2
1988 4
1989 2
1990 10
1991 4
1992 12
1993 11
1994 6
1995 17
1996 9
1997 11
1998 17
1999 21
2000 22
2001 31
2002 36
2003 61
2004 34
2005 44
2006 51
2007 51
2008 53
2009 50
2010 49
2011 54
2012 49
2013 63
2014 83
2015 91
2016 94
2017 118
2018 100
2019 122
2020 139
2021 147
2022 137
2023 128
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

1,772 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Atopic dermatitis.
Langan SM, Irvine AD, Weidinger S. Langan SM, et al. Lancet. 2020 Aug 1;396(10247):345-360. doi: 10.1016/S0140-6736(20)31286-1. Lancet. 2020. PMID: 32738956 Review.
Atopic dermatitis is a common inflammatory skin disorder characterised by recurrent eczematous lesions and intense itch. The disorder affects people of all ages and ethnicities, has a substantial psychosocial impact on patients and relatives, and is the leading caus
Atopic dermatitis is a common inflammatory skin disorder characterised by recurrent eczematous lesions and intense itch. The d
Novel insights into atopic dermatitis.
Schuler CF 4th, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE. Schuler CF 4th, et al. J Allergy Clin Immunol. 2023 May;151(5):1145-1154. doi: 10.1016/j.jaci.2022.10.023. Epub 2022 Nov 22. J Allergy Clin Immunol. 2023. PMID: 36428114 Review.
Recent research into the pathophysiology and treatment of atopic dermatitis (AD) has shown notable progress. An increasing number of aspects of the immune system are being implicated in AD, including the epithelial barrier, T(H)2 cytokines, and mast cells. .. …
Recent research into the pathophysiology and treatment of atopic dermatitis (AD) has shown notable progress. An increasing num …
Pathophysiology of atopic dermatitis: Clinical implications.
Kim J, Kim BE, Leung DYM. Kim J, et al. Allergy Asthma Proc. 2019 Mar 1;40(2):84-92. doi: 10.2500/aap.2019.40.4202. Allergy Asthma Proc. 2019. PMID: 30819278 Free PMC article. Review.
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. ...Type 2 cytokines as well as interleukin 17 and interleukin 22 contribute to skin barrier dysfunction and the development of AD. ...
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. ...Type 2 cytokines as well as interleukin
Brief Academic Review and Clinical Practice Guidelines for Pediatric Atopic Dermatitis.
Yang YB, Gohari A, Lam J. Yang YB, et al. Curr Pediatr Rev. 2021;17(3):229-237. doi: 10.2174/1573396316999200820163434. Curr Pediatr Rev. 2021. PMID: 32867653 Review.
In this clinical guidelines article, we first include a brief review of the epidemiology, pathogenesis, clinical diagnoses, and scoring-scales for pediatric atopic dermatitis (AD). We then offer a set of pharmacologic treatment guidelines for infants and toddlers (& …
In this clinical guidelines article, we first include a brief review of the epidemiology, pathogenesis, clinical diagnoses, and scoring-scal …
JAK inhibitors in the treatment of atopic dermatitis.
Chovatiya R, Paller AS. Chovatiya R, et al. J Allergy Clin Immunol. 2021 Oct;148(4):927-940. doi: 10.1016/j.jaci.2021.08.009. Epub 2021 Aug 24. J Allergy Clin Immunol. 2021. PMID: 34437922 Free PMC article. Review.
Atopic dermatitis (AD) is a chronic inflammatory skin disorder associated with heterogenous presentation and often immense patient burden. ...Delgocitinib ointment was recently approved in Japan for pediatric and adult AD. Oral JAK inhibitors include baricitinib (JA
Atopic dermatitis (AD) is a chronic inflammatory skin disorder associated with heterogenous presentation and often immense pat
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.
Bieber T. Bieber T. Nat Rev Drug Discov. 2022 Jan;21(1):21-40. doi: 10.1038/s41573-021-00266-6. Epub 2021 Aug 20. Nat Rev Drug Discov. 2022. PMID: 34417579 Free PMC article. Review.
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. ...In addition to regulatory approval for the IL-4Ra inhibitor dupilumab, the anti-IL-13 inhibitor tralokinumab
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spec
Overview of atopic dermatitis.
Avena-Woods C. Avena-Woods C. Am J Manag Care. 2017 Jun;23(8 Suppl):S115-S123. Am J Manag Care. 2017. PMID: 28978208 Free article. Review.
Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory skin condition. Incidence of AD has increased 2- to 3-fold in industrialized nations, impacting approximately 15% to 20% of children and 1% to 3% of adults worldwi
Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory skin condition. Incidence of A
Treatment With Dupilumab in Patients With Atopic Dermatitis: Systematic Review and Meta-Analysis.
Koskeridis F, Evangelou E, Ntzani EE, Kostikas K, Tsabouri S. Koskeridis F, et al. J Cutan Med Surg. 2022 Nov-Dec;26(6):613-621. doi: 10.1177/12034754221130969. Epub 2022 Oct 9. J Cutan Med Surg. 2022. PMID: 36214355 Review.
Atopic dermatitis (AD) is a type 2 chronic skin disorder associated with systemic and psychosocial comorbidities decreasing the quality of life for many patients. ...It also achieved a reduction of at least 75% in the EASI score [Risk Ratio (RR) = 2.89
Atopic dermatitis (AD) is a type 2 chronic skin disorder associated with systemic and psychosocial comorbidities decrea
Atopic dermatitis.
Weidinger S, Novak N. Weidinger S, et al. Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X. Epub 2015 Sep 13. Lancet. 2016. PMID: 26377142 Review.
Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. ...Originally regarded as a childhood disorder mediated by an imbalance towards a T-helper-2
Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense
Subtypes of atopic dermatitis: From phenotype to endotype.
Tokura Y, Hayano S. Tokura Y, et al. Allergol Int. 2022 Jan;71(1):14-24. doi: 10.1016/j.alit.2021.07.003. Epub 2021 Jul 31. Allergol Int. 2022. PMID: 34344611 Free article. Review.
Atopic dermatitis (AD) is a heterogenous disorder and can be classified into different types. ...Endotype is defined as the molecular mechanisms underlying the visible features/phenotype. Endotype repertoire harbors activation of type 2 cytokines, type 1 cyto
Atopic dermatitis (AD) is a heterogenous disorder and can be classified into different types. ...Endotype is defined as the mo
1,772 results